6-K - Regentis Biomaterials Ltd. | StockGist

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance

Exhibits (2)

6-K

REPORT OF FOREIGN PRIVATE ISSUER

99.1

PRESS RELEASE TITLED: "REGENTIS BIOMATERIALS APPOINTS ORI GON AS CHIEF FINANCIAL OFFICER AND CHIEF BUSINESS OFFICER AS GELRINC PROGRESSES TOWARDS COMMERCIAL LAUNCH IN EUROPE AND ADVANCES IN U.S. PHASE III FDA TRIAL."